Literature DB >> 25675529

Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area.

Sabine Krabbe1, Johanna Duda2, Julia Schiemann1, Christina Poetschke2, Gaby Schneider3, Eric R Kandel4, Birgit Liss2, Jochen Roeper1, Eleanor H Simpson5.   

Abstract

There is strong evidence that the core deficits of schizophrenia result from dysfunction of the dopamine (DA) system, but details of this dysfunction remain unclear. We previously reported a model of transgenic mice that selectively and reversibly overexpress DA D2 receptors (D2Rs) in the striatum (D2R-OE mice). D2R-OE mice display deficits in cognition and motivation that are strikingly similar to the deficits in cognition and motivation observed in patients with schizophrenia. Here, we show that in vivo, both the firing rate (tonic activity) and burst firing (phasic activity) of identified midbrain DA neurons are impaired in the ventral tegmental area (VTA), but not in the substantia nigra (SN), of D2R-OE mice. Normalizing striatal D2R activity by switching off the transgene in adulthood recovered the reduction in tonic activity of VTA DA neurons, which is concordant with the rescue in motivation that we previously reported in our model. On the other hand, the reduction in burst activity was not rescued, which may be reflected in the observed persistence of cognitive deficits in D2R-OE mice. We have identified a potential molecular mechanism for the altered activity of DA VTA neurons in D2R-OE mice: a reduction in the expression of distinct NMDA receptor subunits selectively in identified mesolimbic DA VTA, but not nigrostriatal DA SN, neurons. These results suggest that functional deficits relevant for schizophrenia symptoms may involve differential regulation of selective DA pathways.

Entities:  

Keywords:  NMDA receptor; burst activity; dopamine D2 receptor; schizophrenia; ventral tegmental area

Mesh:

Substances:

Year:  2015        PMID: 25675529      PMCID: PMC4378386          DOI: 10.1073/pnas.1500450112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Measuring burstiness and regularity in oscillatory spike trains.

Authors:  Markus Bingmer; Julia Schiemann; Jochen Roeper; Gaby Schneider
Journal:  J Neurosci Methods       Date:  2011-08-18       Impact factor: 2.390

Review 2.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

Review 3.  The mysterious motivational functions of mesolimbic dopamine.

Authors:  John D Salamone; Mercè Correa
Journal:  Neuron       Date:  2012-11-08       Impact factor: 17.173

4.  Extracellular dopamine levels in striatal subregions track shifts in motivation and response cost during instrumental conditioning.

Authors:  Sean B Ostlund; Kate M Wassum; Niall P Murphy; Bernard W Balleine; Nigel T Maidment
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

5.  In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons.

Authors:  L B Jones; G D Stanwood; B S Reinoso; R A Washington; H Y Wang; E Friedman; P Levitt
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 6.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

7.  Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo.

Authors:  K Chergui; P J Charléty; H Akaoka; C F Saunier; J L Brunet; M Buda; T H Svensson; G Chouvet
Journal:  Eur J Neurosci       Date:  1993-02-01       Impact factor: 3.386

8.  Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

Authors:  Christoph Kellendonk; Eleanor H Simpson; H Jonathan Polan; Gaël Malleret; Svetlana Vronskaya; Vanessa Winiger; Holly Moore; Eric R Kandel
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

9.  Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia.

Authors:  Ryan D Ward; Eleanor H Simpson; Vanessa L Richards; Gita Deo; Kathleen Taylor; John I Glendinning; Eric R Kandel; Peter D Balsam
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

10.  K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration.

Authors:  Julia Schiemann; Falk Schlaudraff; Verena Klose; Markus Bingmer; Susumu Seino; Peter J Magill; Kareem A Zaghloul; Gaby Schneider; Birgit Liss; Jochen Roeper
Journal:  Nat Neurosci       Date:  2012-08-19       Impact factor: 24.884

View more
  29 in total

Review 1.  Using human brain imaging studies as a guide toward animal models of schizophrenia.

Authors:  S S Bolkan; F Carvalho Poyraz; C Kellendonk
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

2.  Lower Affinity of Isradipine for L-Type Ca2+ Channels during Substantia Nigra Dopamine Neuron-Like Activity: Implications for Neuroprotection in Parkinson's Disease.

Authors:  Nadine J Ortner; Gabriella Bock; Antonios Dougalis; Maria Kharitonova; Johanna Duda; Simon Hess; Petronel Tuluc; Thomas Pomberger; Nadia Stefanova; Florian Pitterl; Thomas Ciossek; Herbert Oberacher; Henning J Draheim; Peter Kloppenburg; Birgit Liss; Jörg Striessnig
Journal:  J Neurosci       Date:  2017-06-07       Impact factor: 6.167

3.  Striatal dopamine D2 receptors regulate effort but not value-based decision making and alter the dopaminergic encoding of cost.

Authors:  Ina Filla; Matthew R Bailey; Elke Schipani; Vanessa Winiger; Chris Mezias; Peter D Balsam; Eleanor H Simpson
Journal:  Neuropsychopharmacology       Date:  2018-07-20       Impact factor: 7.853

4.  Long-term dopamine neurochemical monitoring in primates.

Authors:  Helen N Schwerdt; Hideki Shimazu; Ken-Ichi Amemori; Satoko Amemori; Patrick L Tierney; Daniel J Gibson; Simon Hong; Tomoko Yoshida; Robert Langer; Michael J Cima; Ann M Graybiel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-20       Impact factor: 11.205

5.  CaV3.1 isoform of T-type calcium channels supports excitability of rat and mouse ventral tegmental area neurons.

Authors:  Matthew E Tracy; Vesna Tesic; Tamara Timic Stamenic; Srdjan M Joksimovic; Nicolas Busquet; Vesna Jevtovic-Todorovic; Slobodan M Todorovic
Journal:  Neuropharmacology       Date:  2018-03-23       Impact factor: 5.250

6.  Dcc haploinsufficiency regulates dopamine receptor expression across postnatal lifespan.

Authors:  Matthew Pokinko; Alanna Grant; Florence Shahabi; Yvan Dumont; Colleen Manitt; Cecilia Flores
Journal:  Neuroscience       Date:  2017-01-17       Impact factor: 3.590

Review 7.  Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia.

Authors:  Nao Chuhma; Susana Mingote; Abigail Kalmbach; Leora Yetnikoff; Stephen Rayport
Journal:  Biol Psychiatry       Date:  2016-07-12       Impact factor: 13.382

8.  The impact of motivation on cognitive performance in an animal model of the negative and cognitive symptoms of schizophrenia.

Authors:  Ryan D Ward; Vanessa Winiger; Kerin K Higa; Julia B Kahn; Eric R Kandel; Peter D Balsam; Eleanor H Simpson
Journal:  Behav Neurosci       Date:  2015-04-27       Impact factor: 1.912

Review 9.  Dopamine Does Double Duty in Motivating Cognitive Effort.

Authors:  Andrew Westbrook; Todd S Braver
Journal:  Neuron       Date:  2016-02-17       Impact factor: 17.173

10.  Striatal dopamine 2 receptor upregulation during development predisposes to diet-induced obesity by reducing energy output in mice.

Authors:  Marie A Labouesse; Andrea M Sartori; Oliver Weinmann; Eleanor H Simpson; Christoph Kellendonk; Ulrike Weber-Stadlbauer
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.